KRT88P and chronic hepatitis B virus infection: Similarly, chronic hepatitis B reactivation, due to siltuximab usage, should also be considered in chronic hepatitis B high prevalent nations such as Korea; we routinely use a prophylaxis dose of oral Entecavir 0.5 mg daily in patients with positive core antibody IgG (HBc-Ab IgG positive).